XML 11 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Balance Sheets - EUR (€)
€ in Millions
Jun. 30, 2025
Dec. 31, 2024
Assets    
Property, plant and equipment owned [1] € 9,574 € 10,091
Right-of-use assets [1] 1,433 1,510
Goodwill [1] 40,283 43,384
Other intangible assets [1] 20,431 22,629
Investments accounted for using the equity method [1] 3,563 316
Other non-current assets [1] 4,109 3,753
Non-current income tax assets [1] 541 560
Deferred tax assets [1] 8,008 7,967
Non-current assets [1] 87,942 90,210
Inventories [1] 9,618 9,431
Accounts receivable [1] 7,810 7,677
Other current assets [1] 3,595 3,826
Current income tax assets [1] 397 724
Cash and cash equivalents [1] 15,359 7,441
Assets held for sale [1] 238 13,489
Current assets [1] 37,017 42,588
Total assets [1] 124,959 132,798
Equity and liabilities    
Equity attributable to equity holders of Sanofi [1] 70,008 77,507
Equity attributable to non-controlling interests [1] 271 350
Total equity [1] 70,279 77,857
Long-term debt [1] 13,200 11,791
Non-current lease liabilities [1] 1,524 1,645
Non-current liabilities related to business combinations and to non-controlling interests [1] 564 [2] 569
Non-current provisions and other non-current liabilities [1] 7,116 8,096
Non-current income tax liabilities [1] 1,502 1,512
Deferred tax liabilities [1] 1,715 2,166
Non-current liabilities [1] 25,621 25,779
Accounts payable [1] 7,075 7,551
Current liabilities related to business combinations and to non-controlling interests [1] 0 [2] 72
Current provisions and other current liabilities [1] 13,697 14,241
Current income tax liabilities [1] 724 697
Current lease liabilities [1] 252 261
Short-term debt and current portion of long-term debt [1] 7,309 4,209
Liabilities related to assets held for sale [1] 2 2,131
Current liabilities [1] 29,059 29,162
Total equity and liabilities [1] € 124,959 € 132,798
[1] These unaudited condensed half year consolidated financial statements as of June 30, 2025 should be read in conjunction with Sanofi’s audited consolidated financial statements as of December 31, 2024.
[2] As of January 1, 2025, this comprised a non-current portion of €569 million and a current portion of €72 million.